These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1151655)

  • 21. Some substituted naphthazarins as potential anticancer agents.
    Paull KD; Zee-Cheng RK; Cheng CC
    J Med Chem; 1976 Feb; 19(2):337-9. PubMed ID: 1061817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth.
    van den Broek LA; Liskamp RM; Colstee JH; Lelieveld P; Remacha M; Vázquez D; Ballesta JP; Ottenheijm HC
    J Med Chem; 1987 Feb; 30(2):325-33. PubMed ID: 3543365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental studies on the antitumor effect of ethidium bromide and related substances.
    Nishiwaki H; Miura M; Imai K; Ono R; Kawashima K
    Cancer Res; 1974 Oct; 34(10):2699-703. PubMed ID: 4413384
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antitumor evaluation of the presumed cytotoxic metabolites of spermine and N,N'-bis(3-aminopropyl)nonane-1,9-diamine.
    Israel M; Zoll EC; Muhammad N; Modest EJ
    J Med Chem; 1973 Jan; 16(1):1-5. PubMed ID: 4682195
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure-activity relationships in antitumor aniline mustards.
    Panthananickal A; Hansch C; Leo A
    J Med Chem; 1978 Jan; 21(1):16-26. PubMed ID: 619146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of some acylhydrazines.
    Rutner H; Lewin N; Woodbury EC; McBride RJ; Rao KV
    Cancer Chemother Rep; 1974; 58(6):803-10. PubMed ID: 4447923
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sparsomycin analogs. II. Synthesis and biological activities of 5-carboxy-6-methyluracil derivatives.
    Kanatomo S; Nagai S; Hase T; Ohki K; Nomura C; Okezaki E
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):135-43. PubMed ID: 6850930
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 32. Preparation and the results of antitumor screening of some substituted amino-, azido-, halogeno- and hydroxy-p-benzoquinones.
    Zee-Cheng KY; Cheng CC
    J Med Chem; 1970 Mar; 13(2):264-8. PubMed ID: 5418499
    [No Abstract]   [Full Text] [Related]  

  • 33. Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin.
    Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; De Vos D; Doesburg WH; Ottenheijm HC; De Grip WJ
    Invest New Drugs; 1995; 13(1):23-32. PubMed ID: 7499104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor inhibitors. 3. Identification and synthesis of an oncolytic hydrocarbon from American coneflower roots.
    Voaden DJ; Jacobson M
    J Med Chem; 1972 Jun; 15(6):619-23. PubMed ID: 5030929
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of sparsomycin resistance in Streptomyces sparsogenes.
    Lázaro E; Sanz E; Remacha M; Ballesta JP
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2914-9. PubMed ID: 12183247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of potential anticancer agents. Preparation of some 1-deazapurines and pyrimidines.
    Temple C; Smith BH; Elliott RD; Montgomery JA
    J Med Chem; 1973 Mar; 16(3):292-4. PubMed ID: 4733113
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential anticancer agents. 3. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1970 Sep; 13(5):935-41. PubMed ID: 5458385
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation of plant extracts for antitumor screening.
    Statz D; Coon FB
    Cancer Treat Rep; 1976 Aug; 60(8):999-1005. PubMed ID: 991158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.